|
ARMCX5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68665081901054E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.5623283756745E-12 |
| Normal-vs-Stage2 |
1.79739999550677E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.6734391650175E-12 |
| Stage1-vs-Stage2 |
9.113200E-01 |
| Stage1-vs-Stage3 |
3.259700E-03 |
| Stage1-vs-Stage4 |
1.213930E-02 |
| Stage2-vs-Stage3 |
7.339600E-02 |
| Stage2-vs-Stage4 |
9.204400E-02 |
| Stage3-vs-Stage4 |
9.195400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73250302992756E-12 |
| Normal-vs-AfricanAmerican |
1.84341431008761E-12 |
| Normal-vs-Asian |
1.322480E-03 |
| Caucasian-vs-AfricanAmerican |
3.800000E-01 |
| Caucasian-vs-Asian |
6.978600E-01 |
| AfricanAmerican-vs-Asian |
9.632200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.69118061169138E-13 |
| Male-vs-Female |
7.733800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.0427999836723E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63424829224823E-13 |
| Normal-vs-Age(81-100Yrs) |
1.50320000003035E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.661500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.768000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.264800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.986600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.765000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.272800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.197300E-04 |
| Normal-vs-Grade 2 |
2.08749684205145E-11 |
| Normal-vs-Grade 3 |
1.99840144432528E-14 |
| Normal-vs-Grade 4 |
1.62481139653892E-12 |
| Grade 1-vs-Grade 2 |
3.141600E-01 |
| Grade 1-vs-Grade 3 |
5.580200E-02 |
| Grade 1-vs-Grade 4 |
5.155100E-04 |
| Grade 2-vs-Grade 3 |
1.954060E-02 |
| Grade 2-vs-Grade 4 |
4.13150000000417E-05 |
| Grade 3-vs-Grade 4 |
9.877900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.61479948804322E-10 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
2.838100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
5.61180000024919E-07 |
| N0-vs-N1 |
1.351620E-01 |
|
|
